Pruzanski Mark
President & CEO at INTERCEPT PHARMACEUTICALS INC
- Sold, on record
- $59.8M
- Dollars the filings state
- Form 4 sales
- 37
- Latest Dec 31, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- INTERCEPT PHARMACEUTICALS INCPresident & CEO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedApr 3, 2017 2017
Sold 1 shares at $115.00 ($137)
Pruzanski Mark, CEO & President
Sold 0% of holdings ($65.7M position)571,718 shares left0x usual sizeFiling
- 2 Form 4 sale INTERCEPT PHARMACEUTICALS INCUnusualJun 26, 2017 +84 days
Sold 40,000 shares at $130.80 ($5.2M)
Pruzanski Mark, CEO & President
Sold 6.5% of holdings ($80M position)571,718 shares left56.3x usual sizeFiling
- 3 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedJul 3, 2017 +7 days
Sold 1,434 shares at $121.78 ($175k)
Pruzanski Mark, CEO & President
Sold 0.3% of holdings ($69.6M position)570,284 shares left1x usual sizeFiling
- 4 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedOct 2, 2017 +91 days
Sold 1,532 shares at $58.87 ($90k)
Pruzanski Mark, CEO & President
Sold 0.3% of holdings ($33.6M position)568,752 shares left1.1x usual sizeFiling
- 5 Form 4 sale INTERCEPT PHARMACEUTICALS INCUnusualNov 16, 2018 +410 days
Sold 50,000 shares at $101.07 ($5.1M)
Pruzanski Mark, President & CEO
Sold 8.1% of holdings ($62.3M position)566,805 shares left32.6x usual sizeFiling
- 6 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedNov 26, 2019 +375 days
Sold 50,000 shares at $100.00 ($5M)
Pruzanski Mark, President & CEO
Sold 9.6% of holdings ($51.9M position)469,126 shares leftFiling
- 7 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedDec 26, 2019 +30 days
Sold 417 shares at $125.00 ($52k)
Pruzanski Mark, President & CEO
Sold 0.1% of holdings ($58.7M position)469,126 shares leftFiling
- 8 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedDec 31, 2019 +5 days
Sold 100 shares at $125.00 ($13k)
Pruzanski Mark, President & CEO
Sold 0% of holdings ($58.7M position)469,126 shares left0x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (37)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | Jan 3, 2020 | INTERCEPT PHARMACEUTICALS INC | President & CEO | Form 4 sale | 100 | $13k | 0.0% | Plan not stated | SEC |
| Dec 26, 2019 | Dec 30, 2019 | INTERCEPT PHARMACEUTICALS INC | President & CEO | Form 4 sale | 417 | $52k | 0.1% | Plan not stated | SEC |
| Nov 26, 2019 | Nov 27, 2019 | INTERCEPT PHARMACEUTICALS INC | President & CEO | Form 4 sale | 50,000 | $5M | 9.6% | Plan not stated | SEC |
| Nov 16, 2018 | Nov 16, 2018 | INTERCEPT PHARMACEUTICALS INC | President & CEO | Form 4 sale | 50,000 | $5.1M | 8.1% | Unusual | SEC |
| Oct 2, 2017 | Oct 4, 2017 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 1,532 | $90k | 0.3% | Plan not stated | SEC |
| Jul 3, 2017 | Jul 5, 2017 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 1,434 | $175k | 0.3% | Plan not stated | SEC |
| Jun 26, 2017 | Jun 28, 2017 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 40,000 | $5.2M | 6.5% | Unusual | SEC |
| Apr 3, 2017 | Apr 5, 2017 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 1 | $137 | 0.0% | Plan not stated | SEC |
| Jan 3, 2017 | Jan 5, 2017 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 2,802 | $291k | 0.5% | Unusual | SEC |
| Oct 3, 2016 | Oct 5, 2016 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 705 | $115k | 0.1% | Plan not stated | SEC |
| Sep 20, 2016 | Sep 22, 2016 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 35,000 | $5.8M | 6.0% | Unusual | SEC |
| Jul 5, 2016 | Jul 7, 2016 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 714 | $104k | 0.1% | Plan not stated | SEC |
| Apr 4, 2016 | Apr 6, 2016 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 708 | $93k | 0.1% | Plan not stated | SEC |
| Jan 4, 2016 | Jan 5, 2016 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 2,126 | $310k | 0.4% | Plan not stated | SEC |
| Oct 2, 2015 | Oct 5, 2015 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 167 | $27k | 0.0% | Plan not stated | SEC |
| Jul 10, 2015 | Jul 14, 2015 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 12,500 | $3.1M | 2.4% | Plan not stated | SEC |
| Jul 2, 2015 | Jul 7, 2015 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 158 | $37k | 0.0% | Plan not stated | SEC |
| May 14, 2015 | May 18, 2015 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 5,000 | $1.5M | 1.0% | Plan not stated | SEC |
| May 1, 2015 | May 5, 2015 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 12,500 | $3.2M | 2.5% | Plan not stated | SEC |
| Apr 2, 2015 | Apr 3, 2015 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 157 | $44k | 0.0% | Plan not stated | SEC |
| Jan 5, 2015 | Jan 7, 2015 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 461 | $81k | 0.1% | Plan not stated | SEC |
| Nov 3, 2014 | Nov 5, 2014 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 10,000 | $2.6M | 2.0% | Plan not stated | SEC |
| Oct 1, 2014 | Oct 3, 2014 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 10,000 | $2.3M | 2.0% | Plan not stated | SEC |
| Sep 2, 2014 | Sep 4, 2014 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 10,000 | $2.9M | 2.1% | Plan not stated | SEC |
| Aug 1, 2014 | Aug 6, 2014 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 10,000 | $2.3M | 2.1% | Plan not stated | SEC |
| Jul 1, 2014 | Jul 3, 2014 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 10,000 | $2.5M | 2.1% | Plan not stated | SEC |
| Jun 2, 2014 | Jun 4, 2014 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 10,000 | $2.3M | 2.1% | Plan not stated | SEC |
| May 1, 2014 | May 2, 2014 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 10,000 | $2.6M | 2.1% | Plan not stated | SEC |
| Apr 16, 2014 | Apr 17, 2014 | INTERCEPT PHARMACEUTICALS INC | CEO & President | Form 4 sale | 10,000 | $2.4M | 2.1% | Plan not stated | SEC |
| Jan 16, 2014 | Jan 17, 2014 | INTERCEPT PHARMACEUTICALS INC | President and CEO | Form 4 sale | 10,000 | $2.7M | 2.3% | Plan not stated | SEC |
| Sep 17, 2013 | Sep 18, 2013 | INTERCEPT PHARMACEUTICALS INC | President and CEO | Form 4 sale | 25,000 | $1.3M | 5.9% | Plan not stated | SEC |
| Sep 13, 2013 | Sep 13, 2013 | INTERCEPT PHARMACEUTICALS INC | President and CEO | Form 4 sale | 12,500 | $613k | 3.0% | Plan not stated | SEC |
| Aug 12, 2013 | Aug 13, 2013 | INTERCEPT PHARMACEUTICALS INC | President and CEO | Form 4 sale | 12,500 | $575k | 3.0% | Plan not stated | SEC |
| Jul 15, 2013 | Jul 16, 2013 | INTERCEPT PHARMACEUTICALS INC | President and CEO | Form 4 sale | 25,000 | $1.3M | 5.9% | Plan not stated | SEC |
| Jul 9, 2013 | Jul 10, 2013 | INTERCEPT PHARMACEUTICALS INC | President and CEO | Form 4 sale | 37,500 | $1.7M | 8.5% | Plan not stated | SEC |
| Jun 26, 2013 | Jun 27, 2013 | INTERCEPT PHARMACEUTICALS INC | President and CEO | Form 4 sale | 12,500 | $501k | 3.0% | Plan not stated | SEC |
| Jun 20, 2013 | Jun 21, 2013 | INTERCEPT PHARMACEUTICALS INC | President and CEO | Form 4 sale | 25,000 | $956k | 5.9% | Plan not stated | SEC |